Kringle Pharma, Inc.'s market cap is currently ¥3.27B. The company's EPS TTM is ¥-33.2; its P/E ratio is ―; Kringle Pharma, Inc. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
